Topiramate Tablet, Film Coated
Product Images NDC 43063-997

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 43063-997). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063997 Label (43063997)

This is a medication package of Topiramate tablets, USP, 50mg, containing 30 film-coated tablet in each bottle. The Reorder # is 110845 and the Lot number is G20D20. The tablets should be kept out of reach of children. The package insert should be consulted for dosage and storage instructions. The FDA should be notified about any side effects. The tablets are yellow, round, and imprinted with 43063-997-30. The expiration date is 07/2022. There is no information available regarding the drug's indications or its manufacturer's claims.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure-1jpg (Figure 1)

FDA Label Image

Figure-2 (Figure 2)

This appears to be a table showing the results of a study on the effectiveness of Topiramate, with different dosages of the drug (50mg/day, 100mg/day, and 200mg/day) being compared to a placebo. The study evaluated the medication's impact on the monthly migraine period rate, with the data presented indicating a change from baseline to double-blind. The study was conducted across two different groups (referred to as EEl Study 11 and Study 2), and the results indicate statistical significance, with p-values of less than 0.010 and 0.001.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.